Cargando…

Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier

In this study, a glycyrrhetinic acid-functionalized mesoporous silica nanoparticle (MSN-GA) was prepared for active tumor targeting. MSN-GA exhibited satisfactory loading capacity for insoluble drugs, uniform size distribution, and specific tumor cell targeting. Glycyrrhetinic acid, a hepatocellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Yongjiu, Li, Jingjing, Chen, Huali, Bai, Yan, Zhang, Liangke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476610/ https://www.ncbi.nlm.nih.gov/pubmed/28652738 http://dx.doi.org/10.2147/IJN.S135626

Ejemplares similares

Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells
por: Martínez-Edo, Gabriel, et al.
Publicado: (2020)

Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid
por: Li, Jingjing, et al.
Publicado: (2015)

Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury
por: Guo, Xinghua, et al.
Publicado: (2023)

Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
por: Castillo, Rafael R., et al.
Publicado: (2020)

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021)

An Assessment of Mesoporous Silica Nanoparticle Architectures as Antigen Carriers
por: Huang, Xinyue, et al.
Publicado: (2020)

Novel multifunctional pH-sensitive nanoparticles loaded into microbubbles as drug delivery vehicles for enhanced tumor targeting
por: Lv, Yongjiu, et al.
Publicado: (2016)

Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection
por: Peng, Xuqi, et al.
Publicado: (2021)

Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
por: Cha, Wenzhang, et al.
Publicado: (2017)

Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma
por: Xu, Yilin, et al.
Publicado: (2022)

Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier
por: Li, Qi, et al.
Publicado: (2021)

Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma
por: Cao, Mingzhuo, et al.
Publicado: (2019)

Mesoporous silica nanoparticles for drug and gene delivery
por: Zhou, Yixian, et al.
Publicado: (2018)

Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres
por: Liao, Yu-Te, et al.
Publicado: (2014)

Exploring mesoporous silica nanoparticles as oral insulin carriers: In-silico and in vivo evaluation
por: Salarkia, Ehsan, et al.
Publicado: (2023)

Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells
por: Kong, Zwe-Ling, et al.
Publicado: (2019)

Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
por: Singh, Neetu, et al.
Publicado: (2011)

Silica-based mesoporous nanoparticles for controlled drug delivery
por: Kwon, Sooyeon, et al.
Publicado: (2013)

Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
por: Vallet-Regí, María, et al.
Publicado: (2017)

Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer
por: Watermann, Anna, et al.
Publicado: (2017)

Preparation and Applications of Organo-Silica Hybrid Mesoporous Silica Nanoparticles for the Co-Delivery of Drugs and Nucleic Acids
por: Pontón, Iris, et al.
Publicado: (2020)

Biosafety of Mesoporous Silica Nanoparticles
por: Rascol, Estelle, et al.
Publicado: (2018)

Mesoporous Silica Nanoparticles in Bioimaging
por: Yuan, Daohe, et al.
Publicado: (2020)

Mesoporous silica nanoparticles in target drug delivery system: A review
por: Bharti, Charu, et al.
Publicado: (2015)

Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020)

Functionalized Mesoporous Silica as Doxorubicin Carriers and Cytotoxicity Boosters
por: Racles, Carmen, et al.
Publicado: (2022)

Mesoporous Silica Nanoparticles for Targeting Subcellular Organelles
por: Gisbert-Garzarán, Miguel, et al.
Publicado: (2020)

A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol
por: Han, Cuiyan, et al.
Publicado: (2019)

Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
por: Paris, Juan L., et al.
Publicado: (2020)

Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility
por: Hu, Beibei, et al.
Publicado: (2020)

Galactosylated chitosan-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
por: Liu, Wei, et al.
Publicado: (2018)

The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice
por: Lee, Soyoung, et al.
Publicado: (2013)

Synthesis of glycyrrhetinic acid-modified liposomes to deliver Murrayafoline A for treatment of hepatocellular carcinoma
por: Dinh, Cuc Thi, et al.
Publicado: (2022)

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
por: Zuo, Jiawei, et al.
Publicado: (2023)

Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes
por: Sun, Yuqi, et al.
Publicado: (2018)

Multiple-Responsive Mesoporous Silica Nanoparticles for Highly Accurate Drugs Delivery to Tumor Cells
por: Jin, Ronghua, et al.
Publicado: (2018)

Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity
por: Xue, Hantao, et al.
Publicado: (2021)

Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery
por: Chen, Hongmin, et al.
Publicado: (2013)

Phospholipid-Coated Mesoporous Silica Nanoparticles Acting as Lubricating Drug Nanocarriers
por: Sun, Tao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u6f8lo6ke90epf7hrjidr0tos3